These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1480273)

  • 1. Contribution of thallium-201-SPECT to the grading of tumorous alterations of the brain.
    Burkard R; Kaiser KP; Wieler H; Klawki P; Linkamp A; Mittelbach L; Göller T
    Neurosurg Rev; 1992; 15(4):265-73. PubMed ID: 1480273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of malignancy in ring enhancing brain lesions on CT by thallium-201 SPECT.
    Källén K; Heiling M; Andersson AM; Brun A; Holtås S; Ryding E; Rosén I
    J Neurol Neurosurg Psychiatry; 1997 Nov; 63(5):569-74. PubMed ID: 9408094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of malignant glioma and metastatic brain tumor by thallium-201 single photon emission computed tomography.
    Kojima Y; Kuwana N; Noji M; Tosa J
    Neurol Med Chir (Tokyo); 1994 Sep; 34(9):588-92. PubMed ID: 7526248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thallium imaging for brain tumors with results measured by a semiquantitative index and correlated with histopathology.
    Slizofski WJ; Krishna L; Katsetos CD; Black P; Miyamoto C; Brown SJ; Vender J; Chevres A; Khan AS; McEwan J
    Cancer; 1994 Dec; 74(12):3190-7. PubMed ID: 7982182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of thallium-201 uptake and retention indices for evaluation of brain lesions with SPECT.
    Katano H; Karasawa K; Sugiyama N; Yamashita N; Ohkura A; Watanabe K; Kamiya K
    J Clin Neurosci; 2002 Nov; 9(6):653-8. PubMed ID: 12604277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas.
    Black KL; Hawkins RA; Kim KT; Becker DP; Lerner C; Marciano D
    J Neurosurg; 1989 Sep; 71(3):342-6. PubMed ID: 2549223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative grading of glioma malignancy with thallium-201 single-photon emission CT: comparison with conventional CT.
    Källén K; Heiling M; Andersson AM; Brun A; Holtås S; Ryding E
    AJNR Am J Neuroradiol; 1996 May; 17(5):925-32. PubMed ID: 8733968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of thallium-201 single photon emission computed tomography to quantify the malignancy grade of brain tumors.
    Igase K; Oka Y; Ohta S; Murakami Y; Kumon Y; Sakaki S
    Neurol Med Chir (Tokyo); 1996 Jul; 36(7):434-9. PubMed ID: 8741372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semiquantitative analysis using thallium-201 SPECT for differential diagnosis between tumor recurrence and radiation necrosis after gamma knife surgery for malignant brain tumors.
    Matsunaga S; Shuto T; Takase H; Ohtake M; Tomura N; Tanaka T; Sonoda M
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):47-52. PubMed ID: 22541963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
    Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM
    Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
    Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
    J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time sequential single photon emission computed tomography studies in brain tumour using thallium-201.
    Ueda T; Kaji Y; Wakisaka S; Watanabe K; Hoshi H; Jinnouchi S; Futami S
    Eur J Nucl Med; 1993 Feb; 20(2):138-45. PubMed ID: 8440270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indium-111-pentetreotide imaging in intra-axial brain tumors: comparison with thallium-201 SPECT and MRI.
    Lee JD; Kim DI; Lee JT; Chang JW; Park CY
    J Nucl Med; 1995 Apr; 36(4):537-41. PubMed ID: 7699438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of 201Tl SPECT in patients with glioma: a comparative study with histological diagnosis, clinical feature and proliferative activity].
    Oriuchi N; Tamura M; Shibazaki T; Inoue T; Watanabe N; Tateno M; Tomiyoshi K; Hirano T; Igarashi H; Endo K
    Kaku Igaku; 1991 Nov; 28(11):1263-71. PubMed ID: 1770641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential diagnosis between recurrence of gliomas and radiation necrosis by 201TlCl SPECT].
    Nakamura O; Kosuda S; Okamoto K; Kaneko M; Nakamura H; Shitara N; Suzuki K
    No To Shinkei; 1994 Nov; 46(11):1051-7. PubMed ID: 7873278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of thallium-201 uptake with proliferating cell nuclear antigen in brain tumours.
    Gungor F; Bezircioglu H; Guvenç G; Tezcan M; Yildiz A; Uluc E; Isisag A
    Nucl Med Commun; 2000 Sep; 21(9):803-10. PubMed ID: 11065152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.
    Sasaki M; Kuwabara Y; Yoshida T; Nakagawa M; Fukumura T; Mihara F; Morioka T; Fukui M; Masuda K
    Eur J Nucl Med; 1998 Sep; 25(9):1261-9. PubMed ID: 9724375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the extension of cerebral gliomas by scintigraphy.
    Weckesser M; Matheja P; Rickert C; Löttgen J; Palkovic S; Riemann B; Paulus W; Wassmann H; Schober O
    Strahlenther Onkol; 2000 Apr; 176(4):180-5. PubMed ID: 10812391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of 201Tl SPECT imaging to assess the response to therapy in patients with high grade gliomas.
    Vallejos V; Balaña C; Fraile M; Roussos Y; Capellades J; Cuadras P; Ballester R; Ley A; Arellano A; Rosell R
    J Neurooncol; 2002 Aug; 59(1):81-90. PubMed ID: 12222842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative residual tumour imaged by contrast-enhanced computed tomography and 201Tl single photon emission tomography: can they predict progression-free survival in high-grade gliomas?
    Datta NR; Pasricha R; Gambhir S; Phadke RV; Prasad SN
    Clin Oncol (R Coll Radiol); 2004 Oct; 16(7):494-500. PubMed ID: 15490813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.